University of Cincinnati College of Law bar results announced

86% of Cincinnati Law first-time takers pass the July 2019 Ohio bar exam.

Graduates of the University of Cincinnati College of Law recorded an 86% passage rate among first-time takers sitting for the Ohio bar exam, outpacing the statewide first-time pass rate of 82%.

The passage rate for all Cincinnati Law graduates sitting for the Ohio bar exam was 81%, exceeding the state-wide passage rate of 73.1%. Eight hundred eighty-five aspiring attorneys from across the state and the country took the July exam.

In addition, for those out-of-state jurisdictions that have release their outcomes, the Class of 2019 have recorded an 82% pass rate. Graduates earned a 100% pass rates in Illinois, Indiana, Massachusetts, Pennsylvania, Washington and West Virginia.

Applicants who successfully passed the examination and who satisfied all of the Supreme Court’s other requirements for admission will be invited to take the attorney oath of office on at 10:30 a.m., Nov. 12, 2019, during a special session of the Supreme Court of Ohio at the Palace Theatre in Columbus, Ohio.

Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.